[Morning News Briefing] First U.S. INJ Staking ETF Begins Trading, etc.
Original headline[모닝 뉴스브리핑] 미국 첫 INJ 스테이킹 ETF 거래 시작 外
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Canary Capital’s staking-enabled Injective (INJ) ETF began trading on Nasdaq on Nov. 5 under the ticker INJC, marking the first U.S. INJ staking ETF and reflecting net staking rewards in its net asset value. Separately, Glassnode’s Oct. 28 weekly report showed Hyperliquid HIP-3 average daily volume reached $2.6 billion in the prior week, surpassing Bitcoin perpetual futures at $2.4 billion, with HIP-3 covering equities as well as index- and commodity-linked contracts. The INJ listing expands U.S. access to staking-linked altcoin exposure, while HIP-3’s volume lead signals growing demand for non-crypto-native perpetual markets. Watch INJC’s early flows and staking-reward treatment, and whether HIP-3 sustains its volume edge over BTC perps.
Muhabbit's AI wrote this summary in its own words from TokenPost's report and translated it from Korean. It can get details wrong, so check the source.
Named in this story
Injective (INJ), Canary Capital, Hyperliquid (HYPE), Nasdaq, Glassnode
A linked name opens that asset's sentiment page.